Home DatasetsExperiment Details
E-GEOD-56717 GSE56717 transcription profiling by array Homo sapiens

Expression data from human metastatic melanoma cell lines

·Released June 10, 2014 ·Updated June 18, 2015
15
Samples
15
Assays
1
Array Platforms
1
References
Description

The genetic changes underlying metastatic melanoma need to be deciphered to develop new and effective therapeutics. Previously, genome-wide microarray analyses of human melanoma identified two reciprocal gene expression programs, that included expression of mRNAs regulated by either transforming growth factor, beta 1 (TGFB1) pathways or microphthalmia-associated transcription factor (MITF)/SRY-box containing gene 10 (SOX10) pathways. We extend this knowledge to include gene expression analyses of 5 additional human melanoma lines, and show that these lines also fall into either TGFB1 or MITF/SOX10 gene expression groups. These mRNA expression studies were followed up by miRNA expression analyses. Microarray analyses were performed on 5 metastatic melanoma lines in 3 replicates. Standard Affymetrix protocols were used.

References
Array Platforms
A-AFFY-37
Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2](15 items)
Sample Attributes
cell line
0380MMU, 0620LNA, 0708LND, UACC3093, UACC647
disease
metastatic melanoma
organism
Homo sapiens
tumor stage
metastatic
Experiment Info
Accession
E-GEOD-56717
GEO ID
GSE56717
Type
transcription profiling by array
Organism
Homo sapiens
Released
June 10, 2014
Updated
June 18, 2015
Submitter
William J Pavan、 Bhavesh Borate、 Julia C Cronin、 Laura L Baxter、 Stacie K Loftus、 Niraj S Trivedi、 Hun-Way Hwang、 Laura Baxter
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]